Mike Nathan

But we do. We ask for more referrals. There's a circle back that way. There's not a patient loop back.

That's not true. Sometimes that does happen. Excuse me. It does.

That's not true. Sometimes that does happen. Excuse me. It does.

That's not true. Sometimes that does happen. Excuse me. It does.

That's not systematized.

That's not systematized.

That's not systematized.

So you would not go after a B2C approach, like advertising online, going, pushing in on a strategy on that?

So you would not go after a B2C approach, like advertising online, going, pushing in on a strategy on that?

So you would not go after a B2C approach, like advertising online, going, pushing in on a strategy on that?

If you were going to try to expand into other major metros in the next 18 months, would you have the B2C sorted out before you went to the next market?

If you were going to try to expand into other major metros in the next 18 months, would you have the B2C sorted out before you went to the next market?

If you were going to try to expand into other major metros in the next 18 months, would you have the B2C sorted out before you went to the next market?

Right on. Thank you.

Right on. Thank you.

Right on. Thank you.

My name is Mike Nathan. I sell cellular therapy in-home to the old, affluent, injured, probably, and athletic. We're new, but we've got a million dollars in revenue, half at EBITDA. We would like to get to $25 million.

My name is Mike Nathan. I sell cellular therapy in-home to the old, affluent, injured, probably, and athletic. We're new, but we've got a million dollars in revenue, half at EBITDA. We would like to get to $25 million.

My name is Mike Nathan. I sell cellular therapy in-home to the old, affluent, injured, probably, and athletic. We're new, but we've got a million dollars in revenue, half at EBITDA. We would like to get to $25 million.

So we consider it mobile health care.